Cybersecurity regulations in medical and advanced technology markets are tightening fast. But regulation alone doesn’t create secure products. Execution does.
Here at Novanta, product cybersecurity has evolved from a regulatory obligation to a core capability that strengthens customer relationships and improves outcomes.
Designing Security In, Not Bolting It On
Our approach starts early. We integrate product cybersecurity at the architecture and requirements phase, where teams analyze potential threats, identify vulnerabilities, and define countermeasures before designs are finalized.
Most of the work is deep product understanding, documentation, and disciplined risk analysis. It’s structured, repeatable, and embedded in our quality management systems from development through post-market support.
Learning Through Real Certifications
We treated early regulatory audits and certifications as feedback loops, refining our processes and strengthening our cybersecurity framework. That learning curve now benefits customers directly as they satisfy their audits and certifications with our cyber security products. Additionally, our product cyber security team has been asked to share their knowledge, guidance, instructions, and best practices.
Partnership, Not Policing
We don’t position ourselves as cybersecurity gatekeepers. We act as collaborators.
By sharing documentation, consulting on audit readiness, and exchanging lessons learned across FDA, MDR, and regional regulatory bodies, we help customers move faster with less risk.
The result: better products, smoother approvals, and stronger long-term partnerships.
Product cybersecurity will keep evolving. The companies that win won’t be the ones reacting; they’ll be the ones building expertise early and sharing it openly. That’s the path we’re on.